BRCA2 and neoplasm: Although there was not statistically differences between BRCA1 c.5309G>T carriers group and BRCA2 c.1310_1313delAAGA carriers group in terms of tumor laterality, histopathological subtype, tumor grade, RE and RP expression, we detected proportional differences between patients groups.